FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40556311000001103: AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2029191000001111 AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2029201000001113 AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Is a Magnesium aspartate (magnesium 10mmol) oral powder sachets sugar free true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Is a AsparDose true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has dispensed dose form Powder true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Has specific active ingredient Magnesium aspartate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) 10 sachet Has AMP True AsparDose 243mg (magnesium 10mmol) oral powder sachets (TriOn Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start